共 31 条
[1]
Parkin D.M., Laara E., Muir C.S., Estimates of the worldwide frequency of sixteen major cancers in 1980, Int J Cancer, 41, pp. 184-197, (1988)
[2]
Dupont J., Lee J., Burton G., Et al., Adenocarcinoma of the stomach: Review of 1497 cases, Cancer, 41, pp. 941-947, (1978)
[3]
Ellis D.J., Speirs C., Kingston R.D., Et al., Carcinoembryonic antigen levels in advanced gastric carcinoma, Cancer, 42, pp. 623-625, (1978)
[4]
Ritts R.E., Del Villano B.C., Go V.L.W., Et al., Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the NCI serum bank, Int J Cancer, 33, pp. 339-345, (1984)
[5]
Wobbes T., Thomas C., Segers M., Nagengast F., Evaluation of seven tumor markers (CA50, CA19-9, CA19-9 Truquant, CA72-4, CA195, carcinoembryonic antigen, and tissue polypeptide antigen) in the pretreatment sera of patients with gastric carcinoma, Cancer, 69, pp. 2036-2041, (1992)
[6]
Samloff I.M., Varis K., Ihamaki T., Et al., Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology: A study in relatives of patients with pernicious anemia, Gastroenterology, 83, pp. 204-209, (1982)
[7]
Varis K., Samloff I.M., Ihamaki T., Siurala M., An appraisal of tests for severe atrophic gastritis in relatives of patients with pernicious anemia, Dig Dis Sci, 24, pp. 187-191, (1979)
[8]
Nomura A., Stemmerman G.N., Samloff I.M., Serum pepsinogen I as a predictor of stomach cancer, Ann Intern Med, 93, pp. 537-540, (1980)
[9]
Stemmermann G.N., Samloff I.M., Nomura A., Heilbrun L.K., Serum pepsinogen I and II and stomach cancer, Clin Chim. Acta, 163, pp. 191-198, (1987)
[10]
Sipponen P., Valle J., Varis K., Et al., Fasting levels of serum gastrin in different functional and morphological states of the antrofundal mucosa: An analysis of 860 subjects, Scand J Gastroenterol, 25, pp. 513-519, (1990)